Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer

NCT00142480 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer
Gallbladder Adenocarcinoma

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Bevacizumab
PROCEDURE: Radiation therapy

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]